BioSpace News Archive

Business

AbCellera and Rallybio Announce Strategic Alliance to Discover, Develop, and Commercialize Novel Antibody-Based Therapeutics for Rare Diseases

AbCellera and Rallybio Corporation announced that they have entered into a strategic alliance to discover, develop, and commercialize novel antibody-based therapeutics for rare diseases.

December 1, 2022
·
7 min read
Drug Development

New Data on Alzstatin for Preventive Treatment Against Alzheimer’s Presented at Alzheimer’s Conference CTAD

AlzeCure Pharma AB announced that the company’s presentation of its research platform Alzstatin, which was presented at the scientific conference CTAD in San Francisco, is now available in its entirety on the company’s website.

December 1, 2022
·
5 min read
Business

Cardior Welcomes Dr. Orly Vardeny as Permanent Guest to the Board

Cardior Pharmaceuticals, a clinical-stage biotech company developing non-coding RNA -based therapeutics for patients with cardiac diseases, announced that Orly Vardeny, PharmD, MS, joins its Board of Directors as a permanent guest.

December 1, 2022
·
3 min read
Lone Star Bio

Enzolytics Recognizes World AIDS Day and Highlights the Company’s Focus on Producing Effective Therapies for Treating HIV

World AIDS Day has been recognized on this day since 1988. It is an important day for the world to reflect on those who have been lost in the HIV pandemic and recommit to the challenge necessary to address this deadly disease.

December 1, 2022
·
13 min read
Policy

Pyxis Oncology Announces FDA Clearance of Two IND Applications

Pyxis Oncology, Inc. announced that it has received clearance for its two Investigational New Drug applications from the U.S. Food and Drug Administration to initiate Phase 1 clinical trials.

December 1, 2022
·
7 min read
Biotech Beach

Catheter Precision’s VIVO™ System Used in More Than 800 Procedures in Leading U.S. and European Hospitals

Catheter Precision, Inc. announces that more than 800 procedures have been performed in a number of leading U.S. and European hospitals utilizing the VIVO System that enables physicians to noninvasively identify an area of ventricular arrhythmia onset.

December 1, 2022
·
15 min read
Business

Tris Pharma and Pediatrix Therapeutics Announce Expansion of Partnership to Commercialize Tris’s ADHD Portfolio and Pipeline Products in China

Tris Pharma, Inc. announced today that they have expanded their partnership whereby Pediatrix Therapeutics received exclusive rights to commercialize Tris’s entire FDA-approved ADHD portfolio as well as ADHD pipeline products in China.

December 1, 2022
·
3 min read
Biotech Bay

Invitae Launches Rare Patient Network for Pediatric Patients With Rare Neurodevelopmental Diseases

Invitae (NYSE: NVTA), a leading medical genetics company, today announced the launch of the Rare Patient Network expanding Invitae’s Ciitizen platform to all patients with pediatric epilepsy and/or developmental delay with plans to include other conditions in the coming months.

December 1, 2022
·
4 min read